Gene · 865
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology. | Blood Adv | 2023 | 37582288 | PubTator, text mining | PubMed |
Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia. | Ann Hematol | 2023 | 37572135 | PubTator, text mining | PubMed |
| Concomitant PIK3CA and TP53 Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis. | J Breast Cancer | 2023 | 37565929 | PubTator, text mining | PubMed |
| Kartogenin-enhanced dynamic hydrogel ameliorates intervertebral disc degeneration via restoration of local redox homeostasis. | J Orthop Translat | 2023 | 37560412 | PubTator, text mining | PubMed |
| An update on intraductal and intralobular proliferative lesions of the breast. | Rev Assoc Med Bras (1992) | 2023 | 37556640 | PubTator, text mining | PubMed |
| APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1. | mBio | 2023 | 37555667 | PubTator, text mining | PubMed |
| BET in hematologic tumors: Immunity, pathogenesis, clinical trials and drug combinations. | Genes Dis | 2023 | 37554207 | PubTator, text mining | PubMed |
| [Venetoclax combined with hypomethylating agents induced tumor lysis syndrome in patients with acute leukemia: 7 cases report and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37550210 | PubTator, text mining | PubMed |
| [Establishment of leukemia cell model with inducible AML1-ETO expression and its effect on fatty acid metabolism in leukemia cells]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37550185 | PubTator, text mining | PubMed |
| Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL). | Clin Epigenetics | 2023 | 37533111 | PubTator, text mining | PubMed |
| Efforts to Grow Genomic Research in Ancestrally Diverse and Admixed Populations. | Cancer Res | 2023 | 37525976 | PubTator, text mining | PubMed |
| A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma. | Sci Rep | 2023 | 37524774 | PubTator, text mining | PubMed |
| A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. | Acta Pharm Sin B | 2023 | 37521858 | PubTator, text mining | PubMed |
| Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex. | Nat Commun | 2023 | 37507366 | PubTator, text mining | PubMed |
| Functional consequences of C-terminal mutations in RUNX2. | Sci Rep | 2023 | 37500953 | PubTator, text mining | PubMed |
| Evolutionary histories of breast cancer and related clones. | Nature | 2023 | 37495687 | PubTator, text mining | PubMed |
| CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer. | Mol Cancer Res | 2023 | 37493631 | PubTator, text mining | PubMed |
| Emerging roles of circular RNAs in stem cells. | Genes Dis | 2023 | 37492713 | PubTator, text mining | PubMed |
| The Contribution of Multiplexing Single Cell RNA Sequencing in Acute Myeloid Leukemia. | Diseases | 2023 | 37489448 | PubTator, text mining | PubMed |
| Epigenetic regulation of bone remodeling and its role in the pathogenesis of primary osteoporosis. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37465189 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/865/papers?page=12